array:25 [
  "pii" => "S0001731021000958"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2020.01.010"
  "estado" => "S300"
  "fechaPublicacion" => "2021-10-01"
  "aid" => "2600"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2021"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2021;112:853-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S1578219021002298"
      "issn" => "15782190"
      "doi" => "10.1016/j.adengl.2021.07.017"
      "estado" => "S300"
      "fechaPublicacion" => "2021-10-01"
      "aid" => "2600"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2021;112:853-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
        "titulo" => "Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "853"
            "paginaFinal" => "856"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Erupci&#243;n pitiriasis rosada-<span class="elsevierStyleItalic">like</span> inducida por imatinib en paciente con tumor del estroma gastrointestinal"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0010"
            "etiqueta" => "Figure 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 2152
                "Ancho" => 2508
                "Tamanyo" => 1364806
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0010"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A&#44; Histologic image highlighting a superficial dermal infiltrate&#46; B&#44; Higher-magnification view showing spongiotic dermatitis with a perivascular infiltrate and focal parakeratosis&#46; C&#44; Detail of predominantly lymphocytic perivascular infiltrate&#46; D&#44; Detail of spongiotic dermatitis with a focus of parakeratosis&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "S&#46; Valenzuela-Ubi&#241;a, I&#46; Villegas-Romero, D&#46; Jim&#233;nez-Gallo, M&#46; Linares-Barrios"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "S&#46;"
                "apellidos" => "Valenzuela-Ubi&#241;a"
              ]
              1 => array:2 [
                "nombre" => "I&#46;"
                "apellidos" => "Villegas-Romero"
              ]
              2 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Jim&#233;nez-Gallo"
              ]
              3 => array:2 [
                "nombre" => "M&#46;"
                "apellidos" => "Linares-Barrios"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0001731021000958"
          "doi" => "10.1016/j.ad.2020.01.010"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021000958?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021002298?idApp=UINPBA000044"
      "url" => "/15782190/0000011200000009/v1_202110091021/S1578219021002298/v1_202110091021/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731020305354"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2019.12.010"
    "estado" => "S300"
    "fechaPublicacion" => "2021-10-01"
    "aid" => "2564"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2021;112:856-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
      "titulo" => "Liposarcoma retroperitoneal en una paciente con una neurofibromatosis tipo 1"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "856"
          "paginaFinal" => "858"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Retroperitoneal Liposarcoma in a Woman With Neurofibromatosis Type 1"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 651
              "Ancho" => 1674
              "Tamanyo" => 118914
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Cl&#237;nica&#58; deformidad abdominal ocasionada por la masa a nivel de flanco derecho &#40;A&#41;&#46; La paciente presenta m&#250;ltiples ef&#233;lides&#44; algunas manchas &#171;caf&#233; con leche&#187; y neurofibromas en el tronco &#40;B&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Bou Boluda, J&#46; Sabater Abad, E&#46; Quecedo Est&#233;banez, A&#46;I&#46; Jim&#233;nez S&#225;nchez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Bou Boluda"
            ]
            1 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Sabater Abad"
            ]
            2 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Quecedo Est&#233;banez"
            ]
            3 => array:2 [
              "nombre" => "A&#46;I&#46;"
              "apellidos" => "Jim&#233;nez S&#225;nchez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020305354?idApp=UINPBA000044"
    "url" => "/00017310/0000011200000009/v1_202110020514/S0001731020305354/v1_202110020514/es/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S000173102100096X"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2020.01.011"
    "estado" => "S300"
    "fechaPublicacion" => "2021-10-01"
    "aid" => "2601"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2021;112:851-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">CARTAS CIENT&#205;FICO-CL&#205;NICAS</span>"
      "titulo" => "Dactilitis granulomatosa como manifestaci&#243;n inusual de la sarcoidosis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "851"
          "paginaFinal" => "853"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Granulomatous Dactylitis&#58; An Unusual Finding in Sarcoidosis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1056
              "Ancho" => 1305
              "Tamanyo" => 168103
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Lesiones de lupus pernio faciales eritematosas con costra en superficie&#46; Dactilitis de 3 dedos del pie derecho asociada a onicopat&#237;a&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "I&#46; Garc&#237;a-Morales, E&#46; S&#225;nchez Garc&#237;a, A&#46; Crespo Cruz, J&#46; Escudero"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Garc&#237;a-Morales"
            ]
            1 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "S&#225;nchez Garc&#237;a"
            ]
            2 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Crespo Cruz"
            ]
            3 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Escudero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219021002365"
        "doi" => "10.1016/j.adengl.2021.07.024"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021002365?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173102100096X?idApp=UINPBA000044"
    "url" => "/00017310/0000011200000009/v1_202110020514/S000173102100096X/v1_202110020514/es/main.assets"
  ]
  "es" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fico-cl&#237;nica</span>"
    "titulo" => "Erupci&#243;n pitiriasis rosada-<span class="elsevierStyleItalic">like</span> inducida por imatinib en paciente con tumor del estroma gastrointestinal"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Sr&#46; Director&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "853"
        "paginaFinal" => "856"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "S&#46; Valenzuela-Ubi&#241;a, I&#46; Villegas-Romero, D&#46; Jim&#233;nez-Gallo, M&#46; Linares-Barrios"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "S&#46;"
            "apellidos" => "Valenzuela-Ubi&#241;a"
            "email" => array:1 [
              0 => "sandra.vzla@hotmail.es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "I&#46;"
            "apellidos" => "Villegas-Romero"
          ]
          2 => array:2 [
            "nombre" => "D&#46;"
            "apellidos" => "Jim&#233;nez-Gallo"
          ]
          3 => array:2 [
            "nombre" => "M&#46;"
            "apellidos" => "Linares-Barrios"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Unidad de Gesti&#243;n Cl&#237;nica de Dermatolog&#237;a M&#233;dico-Quir&#250;rgica y Venereolog&#237;a&#44; Hospital Universitario Puerta del Mar&#44; C&#225;diz&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2151
            "Ancho" => 2508
            "Tamanyo" => 539627
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; M&#250;ltiples m&#225;culas rosadas ovaladas con collarete de descamaci&#243;n&#44; distribuidas sim&#233;tricamente en ambos flancos&#46; B&#41; Detalle de las lesiones localizadas en flanco derecho&#46; C y D&#41; Detalle del collarete de descamaci&#243;n presente en algunas lesiones&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Imatinib es un inhibidor de tirosina-quinasa empleado para el tratamiento de la leucemia mieloide cr&#243;nica &#40;LMC&#41;&#44; los tumores del estroma gastrointestinal &#40;GIST&#41; y el dermatofibrosarcoma protuberans metast&#225;sico<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;5</span></a>&#46; Su mecanismo de acci&#243;n consiste en la inhibici&#243;n competitiva del sitio de uni&#243;n del adenos&#237;n trifosfato &#40;ATP&#41; que&#44; a su vez&#44; impide la fosforilaci&#243;n de las prote&#237;nas BCR-ABL&#44; c-kit y del receptor del factor de crecimiento derivado de plaquetas &#40;PDGFR&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;5&#8211;8</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Una mujer de 78 a&#241;os&#44; diagnosticada de un GIST metast&#225;sico y en tratamiento con imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a desde hac&#237;a un mes y medio&#44; consult&#243; por una erupci&#243;n cut&#225;nea abdominal ligeramente pruriginosa de una semana de evoluci&#243;n&#46; A la exploraci&#243;n se observaban unas m&#225;culas rosadas ovaladas con un collarete de descamaci&#243;n&#44; de distribuci&#243;n sim&#233;trica en ambos flancos &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; El estudio anal&#237;tico realizado fue normal&#44; incluyendo una serolog&#237;a para treponema negativa&#46; La histolog&#237;a revel&#243; una dermatitis espongi&#243;tica con un infiltrado perivascular de predominio linfocitario&#44; con ocasionales eosin&#243;filos y una paraqueratosis focal&#44; compatible con pitiriasis rosada &#40;PR&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#46; Debido al inicio reciente del tratamiento con imatinib y las caracter&#237;sticas histol&#243;gicas&#44; se diagnostic&#243; de erupci&#243;n PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Se suspendi&#243; imatinib y se instaur&#243; tratamiento con betametasona t&#243;pico y loratadina oral&#44; 20<span class="elsevierStyleHsp" style=""></span>mg cada 12<span class="elsevierStyleHsp" style=""></span>h&#44; con una resoluci&#243;n completa de la cl&#237;nica a las 2 semanas&#46; Dada la buena evoluci&#243;n&#44; se reanud&#243; el tratamiento con imatinib a dosis de 100<span class="elsevierStyleHsp" style=""></span>mg cada 12<span class="elsevierStyleHsp" style=""></span>h&#44; aument&#225;ndose progresivamente hasta alcanzar de nuevo los 400<span class="elsevierStyleHsp" style=""></span>mg diarios a las 3 semanas&#44; sin presentar nuevas lesiones cut&#225;neas&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Los efectos adversos de imatinib se clasifican en hematol&#243;gicos y no hematol&#243;gicos<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;8</span></a>&#46; Dentro de los efectos adversos no hematol&#243;gicos los m&#225;s frecuentes son los cut&#225;neos &#40;7-88&#44;9&#37; seg&#250;n series&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;4&#44;8</span></a>&#44; que suelen ser de intensidad leve-moderada&#44; dosis dependientes y no requieren la suspensi&#243;n permanente del f&#225;rmaco<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;4&#44;6&#8211;9</span></a>&#46; Para su tratamiento pueden emplearse antihistam&#237;nicos orales&#44; corticoides t&#243;picos o corticoterapia oral a dosis bajas<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3&#44;8</span></a>&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Las reacciones cut&#225;neas m&#225;s frecuentes son las inespec&#237;ficas&#44; aunque se han descrito casos de pustulosis exantem&#225;tica aguda generalizada&#44; s&#237;ndrome de Stevens-Johnson&#44; micosis fungoide-<span class="elsevierStyleItalic">like</span>&#44; erupciones psoriasiformes&#44; liquen erosivo oral&#44; dermatitis exfoliativas o dermatosis neutrof&#237;licas<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;4&#44;6&#8211;8</span></a>&#46; La erupci&#243;n PR-<span class="elsevierStyleItalic">like</span> es infrecuente y existen pocos casos en la literatura<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">La PR se caracteriza por la presencia de unas m&#225;culas eritematosas con una descamaci&#243;n fina perif&#233;rica en collarete&#44; asintom&#225;ticas o ligeramente pruriginosas&#44; que se resuelven espont&#225;neamente en varias semanas<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">9&#44;10</span></a>&#46; Su etiolog&#237;a es desconocida&#44; relacion&#225;ndose con infecciones como el virus herpes tipo 6 y 7<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">6&#44;9&#44;10</span></a>&#46; Existen tambi&#233;n casos descritos de PR-<span class="elsevierStyleItalic">like</span> inducida por f&#225;rmacos&#44; como omeprazol&#44; metronidazol&#44; terbinafina&#44; captopril&#44; D-penicilamina&#44; isotretino&#237;na&#44; nortriptilina&#44; sales de oro&#44; litio&#44; anti-TNF&#945; e imatinib<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;3&#44;6&#44;9&#44;10</span></a>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">El primer caso de PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib fue descrito por Konstantopoulos et al&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a>&#46; Todos los casos descritos de PR-<span class="elsevierStyleItalic">like</span> por imatinib mostraron lesiones t&#237;picas de PR en el tronco y las extremidades<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3&#44;6&#44;9&#44;10</span></a>&#46; Histol&#243;gicamente presentaron un infiltrado linfocitario perivascular superficial con ocasionales eosin&#243;filos&#44; espongiosis&#44; paraqueratosis focal y queratinocitos necr&#243;ticos&#44; en consonancia con nuestros hallazgos<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3&#44;6&#44;10</span></a>&#46; Algunos mostraban adem&#225;s acantosis y extravasaci&#243;n de hemat&#237;es<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3</span></a>&#46; En nuestra muestra no se realiz&#243; inmunohistoqu&#237;mica para linfocitos CD4&#47;CD8 &#40;podr&#237;a observarse predominio de linfocitos CD8 en epidermis y CD4 en dermis&#41; ni se apreciaban queratinocitos necr&#243;ticos o extravasaci&#243;n de hemat&#237;es&#44; que reforzar&#237;an el origen farmacol&#243;gico&#46; Sin embargo&#44; la histolog&#237;a compatible unida a la relaci&#243;n temporal entre el inicio del f&#225;rmaco y la aparici&#243;n de la cl&#237;nica &#40;mes y medio&#41;&#44; as&#237; como la r&#225;pida resoluci&#243;n &#40;2 semanas&#41; tras la suspensi&#243;n del mismo&#44; apoyan el diagn&#243;stico de PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib&#46; Dichos intervalos de tiempo fueron en consonancia con los recogidos en los otros casos descritos&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">La PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib suele remitir con la suspensi&#243;n del f&#225;rmaco&#44; pudiendo reaparecer si este se reintroduce a dosis elevadas &#40;300-400<span class="elsevierStyleHsp" style=""></span>mg diarios&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3&#44;6</span></a>&#44; lo cual apoya el diagn&#243;stico en estos casos&#46; La relaci&#243;n entre prevalencia y dosis sugiere que es debida a sus efectos sobre la inhibici&#243;n de c-kit y&#47;o PDGFR&#44; los cuales se expresan en queratinocitos&#44; melanocitos&#44; mastocitos y gl&#225;ndulas sudor&#237;paras<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;4&#44;6&#8211;8</span></a>&#46; La cl&#237;nica de nuestra paciente se resolvi&#243; a las 2 semanas de suspender imatinib&#46; Sin embargo&#44; su reintroducci&#243;n no provoc&#243; que las lesiones volvieran a aparecer&#46; Ello podr&#237;a explicarse&#44; como afirman Cho et al&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a>&#44; por un incremento progresivo de dosis&#44; la cual se retom&#243; en nuestra paciente con 100<span class="elsevierStyleHsp" style=""></span>mg cada 12<span class="elsevierStyleHsp" style=""></span>h&#44; alcanzando los 400<span class="elsevierStyleHsp" style=""></span>mg diarios tras 3 semanas libres de lesiones&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Presentamos el que&#44; para nuestro conocimiento&#44; es el primer caso descrito de erupci&#243;n PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib en una paciente con GIST&#46; Existen casos publicados de PR-<span class="elsevierStyleItalic">like</span> por imatinib en pacientes con leucemia mieloide cr&#243;nica &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Se trata de una reacci&#243;n poco frecuente y&#44; generalmente&#44; de car&#225;cter leve&#47;moderado que se resuelve al suspender el f&#225;rmaco&#46; Para prevenir la recidiva del cuadro se plantea la reintroducci&#243;n progresiva de imatinib o&#44; en el caso de GIST&#44; la sustituci&#243;n del mismo por sunitinib&#44; con el que no se han descrito casos&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicto de intereses</span><p id="par0050" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicto de intereses"
        ]
        1 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2151
            "Ancho" => 2508
            "Tamanyo" => 539627
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; M&#250;ltiples m&#225;culas rosadas ovaladas con collarete de descamaci&#243;n&#44; distribuidas sim&#233;tricamente en ambos flancos&#46; B&#41; Detalle de las lesiones localizadas en flanco derecho&#46; C y D&#41; Detalle del collarete de descamaci&#243;n presente en algunas lesiones&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 2152
            "Ancho" => 2508
            "Tamanyo" => 1364806
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A&#41; Imagen histol&#243;gica en la que destaca un infiltrado en dermis superficial&#46; B&#41; A mayor aumento se observa una dermatitis espongi&#243;tica con infiltrado perivascular y paraqueratosis focal&#46; C&#41; Detalle del infiltrado perivascular de predominio linfocitario&#46; D&#41; Detalle de la dermatitis espongi&#243;tica con un foco de paraqueratosis&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patolog&#237;a de base&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Sexo y edad&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tiempo tratamiento y dosis de imatinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Remisi&#243;n lesiones tras suspensi&#243;n&#46; Tratamiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Reinicio imatinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Plan de actuaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cho et al&#46;&#44; <span class="elsevierStyleItalic">Ann Dermatol&#46;</span> 2011&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 74 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 meses&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 semanas&#46; Antihistam&#237;nico oral y corticoide t&#243;pico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">400<span class="elsevierStyleHsp" style=""></span> mg&#47;d&#237;a&#44; reaparici&#243;n de lesiones tras 7 d&#237;as&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sustituci&#243;n por nilotinib&#46; No recurrencia de lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pasmatzi et al&#46;&#44; <span class="elsevierStyleItalic">Acta Derm Venereol&#46;</span> 2003&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 51 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 meses&#44; alternancia de 200-300<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 semanas&#46; Corticoides orales a dosis bajas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">300<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n de lesiones tras 6 d&#237;as&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Imatinib &#40;no precisa dosis&#41; &#43; 4<span class="elsevierStyleHsp" style=""></span>mg metilprednisolona oral d&#237;as alternos&#46; Remisi&#243;n lesiones en 4 meses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Verma et al&#46;&#44; <span class="elsevierStyleItalic">Indian J Dermatol&#46;</span> 2014&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Var&#243;n&#44; 24 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 semanas&#46; Sin tratamiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Aumento progresivo dosis imatinib hasta 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; corticoide t&#243;pico y antihistam&#237;nico oral&#46; Control lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Konstantopoulos et al&#46;&#44; <span class="elsevierStyleItalic">Dermatology&#46;</span> 2002&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 42 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No precisa si resoluci&#243;n&#46; Antihistam&#237;nico oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No se reinicia imatinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sustituci&#243;n por idarubicina &#43; citarabina &#43; corticoide oral&#46; Fallecimiento paciente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Brazzelli et al&#46;&#44; <span class="elsevierStyleItalic">J Am Acad Dermatol&#46;</span> 2005&#40;3 casos&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> LMC<span class="elsevierStyleItalic">2&#41;</span><span class="elsevierStyleBold">LMC</span><span class="elsevierStyleItalic">3&#41;</span> LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> Var&#243;n&#44; 58 a&#241;os<span class="elsevierStyleItalic">2&#41;</span> Var&#243;n&#44; 58 a&#241;os<span class="elsevierStyleItalic">3&#41;</span> Var&#243;n&#44; 35 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> 1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a<span class="elsevierStyleItalic">2&#41;</span> 1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a<span class="elsevierStyleItalic">3&#41;</span> 1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> 2 semanas&#46; Antihistam&#237;nico oral<span class="elsevierStyleItalic">2&#41;</span> No precisa tiempo&#46; Antihistam&#237;nico y corticoide orales<span class="elsevierStyleItalic">3&#41;</span> No precisa tiempo&#46; Antihistam&#237;nico y corticoide orales&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones<span class="elsevierStyleItalic">2&#41;</span> 300<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones leves<span class="elsevierStyleItalic">3&#41;</span> 100<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a una semana y luego 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> Imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; Lesiones ocasionales&#44; no precisan tratamiento<span class="elsevierStyleItalic">2&#41;</span> Imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; Lesiones ocasionales&#44; no precisan tratamiento<span class="elsevierStyleItalic">3&#41;</span> Imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; corticoide oral a dosis bajas&#46; Control lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nuestro caso&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">GIST&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 78 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;5 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 semanas&#46; Corticoide t&#243;pico y antihistam&#237;nico oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100<span class="elsevierStyleHsp" style=""></span>mg&#47;12<span class="elsevierStyleHsp" style=""></span>h&#44; no reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Aumento progresivo dosis imatinib hasta 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; No reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2708768.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Casos de pitiriasis rosada-<span class="elsevierStyleItalic">like</span> inducida por imatinib en la literatura cient&#237;fica</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea-like drug eruption induced by imatinib mesylate &#40;Gleevec&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46;Y&#46; Cho"
                            1 => "D&#46;H&#46; Kim"
                            2 => "M&#46; Im"
                            3 => "Y&#46; Lee"
                            4 => "Y&#46;J&#46; Seo"
                            5 => "J&#46;H&#46; Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5021/ad.2011.23.S3.S360"
                      "Revista" => array:7 [
                        "tituloSerie" => "Ann Dermatol&#46;"
                        "fecha" => "2011"
                        "volumen" => "23"
                        "numero" => "Suppl&#46; 3"
                        "paginaInicial" => "S360"
                        "paginaFinal" => "S363"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22346278"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "E&#46; Pasmatzi"
                            1 => "A&#46; Monastirli"
                            2 => "P&#46; Matsouka"
                            3 => "D&#46; Tsambaos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/00015550310012593"
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Derm Venereol&#46;"
                        "fecha" => "2003"
                        "volumen" => "83"
                        "paginaInicial" => "391"
                        "paginaFinal" => "392"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14609118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Imatinib mesylate-induced cutaneous rash masquerading as pitiriasis rosea of Gilbert"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "P&#46; Verma"
                            1 => "A&#46; Singal"
                            2 => "S&#46; Sharma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4103/0019-5154.131433"
                      "Revista" => array:6 [
                        "tituloSerie" => "Indian J Dermatol&#46;"
                        "fecha" => "2014"
                        "volumen" => "59"
                        "paginaInicial" => "311"
                        "paginaFinal" => "312"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24891677"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Skin lesions in patients treated with imatinib mesylate&#58; A 5-year prospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Paolino"
                            1 => "D&#46; Didona"
                            2 => "R&#46; Clerico"
                            3 => "P&#46; Corsetti"
                            4 => "M&#46; Ambrifi"
                            5 => "U&#46; Bottoni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Cutis"
                        "fecha" => "2016"
                        "volumen" => "97"
                        "paginaInicial" => "E12"
                        "paginaFinal" => "E16"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Approval summary&#58; imatinib mesylate in the treatment of metastatic and&#47;or unresectable malignant gastrointestinal stromal tumors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Dagher"
                            1 => "M&#46; Cohen"
                            2 => "G&#46; Williams"
                            3 => "M&#46; Rothmann"
                            4 => "J&#46; Gobburu"
                            5 => "G&#46; Robbie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Cancer Res&#46;"
                        "fecha" => "2002"
                        "volumen" => "8"
                        "paginaInicial" => "3034"
                        "paginaFinal" => "3038"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12374669"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea-like eruption during treatment with imatinib mesylate&#58; description of 3 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; Brazzelli"
                            1 => "F&#46; Prestinari"
                            2 => "E&#46; Roveda"
                            3 => "T&#46; Barbagallo"
                            4 => "E&#46; Bellani"
                            5 => "C&#46; Vassallo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2004.10.888"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2005"
                        "volumen" => "53"
                        "numero" => "5 Suppl&#46; 1"
                        "paginaInicial" => "S240"
                        "paginaFinal" => "S243"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16227099"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse cutaneous reactions to imatinib &#40;STI571&#41; in Philadelphia chromosome-positive leukemias&#58; a prospective study of 54 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Valeyrie"
                            1 => "S&#46; Bustuji-Garin"
                            2 => "J&#46; Revuz"
                            3 => "N&#46; Bachot"
                            4 => "J&#46; Wechsler"
                            5 => "P&#46; Berthaud"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1067/mjd.2003.44"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2003"
                        "volumen" => "48"
                        "paginaInicial" => "201"
                        "paginaFinal" => "206"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12582389"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia&#58; A 6-year follow up"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "E&#46; Dervis"
                            1 => "M&#46; Ayer"
                            2 => "S&#46; Akin Belli"
                            3 => "S&#46;G&#46; Barut"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1684/ejd.2015.2684"
                      "Revista" => array:5 [
                        "tituloSerie" => "Eur J Dermatol&#46;"
                        "fecha" => "2016"
                        "volumen" => "26"
                        "paginaInicial" => "133"
                        "paginaFinal" => "137"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea associated with Imatinib &#40;STI571&#44; Gleevec&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "K&#46; Konstantopoulos"
                            1 => "A&#46; Papadogianni"
                            2 => "M&#46; Dimopoulou"
                            3 => "C&#46; Kourelis"
                            4 => "J&#46; Meletis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000063900"
                      "Revista" => array:5 [
                        "tituloSerie" => "Dermatology&#46;"
                        "fecha" => "2002"
                        "volumen" => "205"
                        "paginaInicial" => "172"
                        "paginaFinal" => "173"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;K&#46; Bangash"
                            1 => "T&#46; Finch"
                            2 => "V&#46; Petronic-Rosic"
                            3 => "A&#46; Sethi"
                            4 => "E&#46; Abramsohn"
                            5 => "S&#46;T&#46; Lindau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/LGT.0b013e31825d7c5f"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Low Genit Tract Dis&#46;"
                        "fecha" => "2013"
                        "volumen" => "17"
                        "paginaInicial" => "226"
                        "paginaFinal" => "229"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23343697"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011200000009/v1_202110020514/S0001731021000958/v1_202110020514/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6160"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas cient&#237;fico-cl&#237;nicas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011200000009/v1_202110020514/S0001731021000958/v1_202110020514/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021000958?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Carta científico-clínica
Erupción pitiriasis rosada-like inducida por imatinib en paciente con tumor del estroma gastrointestinal
Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor
S. Valenzuela-Ubiña
Corresponding author
sandra.vzla@hotmail.es

Autor para correspondencia.
, I. Villegas-Romero, D. Jiménez-Gallo, M. Linares-Barrios
Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Cádiz, España
Read
10006
Times
was read the article
2162
Total PDF
7844
Total HTML
Share statistics
 array:25 [
  "pii" => "S0001731021000958"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2020.01.010"
  "estado" => "S300"
  "fechaPublicacion" => "2021-10-01"
  "aid" => "2600"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2021"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2021;112:853-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S1578219021002298"
      "issn" => "15782190"
      "doi" => "10.1016/j.adengl.2021.07.017"
      "estado" => "S300"
      "fechaPublicacion" => "2021-10-01"
      "aid" => "2600"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2021;112:853-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
        "titulo" => "Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "853"
            "paginaFinal" => "856"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Erupci&#243;n pitiriasis rosada-<span class="elsevierStyleItalic">like</span> inducida por imatinib en paciente con tumor del estroma gastrointestinal"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0010"
            "etiqueta" => "Figure 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 2152
                "Ancho" => 2508
                "Tamanyo" => 1364806
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0010"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A&#44; Histologic image highlighting a superficial dermal infiltrate&#46; B&#44; Higher-magnification view showing spongiotic dermatitis with a perivascular infiltrate and focal parakeratosis&#46; C&#44; Detail of predominantly lymphocytic perivascular infiltrate&#46; D&#44; Detail of spongiotic dermatitis with a focus of parakeratosis&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "S&#46; Valenzuela-Ubi&#241;a, I&#46; Villegas-Romero, D&#46; Jim&#233;nez-Gallo, M&#46; Linares-Barrios"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "S&#46;"
                "apellidos" => "Valenzuela-Ubi&#241;a"
              ]
              1 => array:2 [
                "nombre" => "I&#46;"
                "apellidos" => "Villegas-Romero"
              ]
              2 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Jim&#233;nez-Gallo"
              ]
              3 => array:2 [
                "nombre" => "M&#46;"
                "apellidos" => "Linares-Barrios"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0001731021000958"
          "doi" => "10.1016/j.ad.2020.01.010"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021000958?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021002298?idApp=UINPBA000044"
      "url" => "/15782190/0000011200000009/v1_202110091021/S1578219021002298/v1_202110091021/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731020305354"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2019.12.010"
    "estado" => "S300"
    "fechaPublicacion" => "2021-10-01"
    "aid" => "2564"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2021;112:856-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
      "titulo" => "Liposarcoma retroperitoneal en una paciente con una neurofibromatosis tipo 1"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "856"
          "paginaFinal" => "858"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Retroperitoneal Liposarcoma in a Woman With Neurofibromatosis Type 1"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 651
              "Ancho" => 1674
              "Tamanyo" => 118914
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Cl&#237;nica&#58; deformidad abdominal ocasionada por la masa a nivel de flanco derecho &#40;A&#41;&#46; La paciente presenta m&#250;ltiples ef&#233;lides&#44; algunas manchas &#171;caf&#233; con leche&#187; y neurofibromas en el tronco &#40;B&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Bou Boluda, J&#46; Sabater Abad, E&#46; Quecedo Est&#233;banez, A&#46;I&#46; Jim&#233;nez S&#225;nchez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Bou Boluda"
            ]
            1 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Sabater Abad"
            ]
            2 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Quecedo Est&#233;banez"
            ]
            3 => array:2 [
              "nombre" => "A&#46;I&#46;"
              "apellidos" => "Jim&#233;nez S&#225;nchez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020305354?idApp=UINPBA000044"
    "url" => "/00017310/0000011200000009/v1_202110020514/S0001731020305354/v1_202110020514/es/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S000173102100096X"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2020.01.011"
    "estado" => "S300"
    "fechaPublicacion" => "2021-10-01"
    "aid" => "2601"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2021;112:851-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">CARTAS CIENT&#205;FICO-CL&#205;NICAS</span>"
      "titulo" => "Dactilitis granulomatosa como manifestaci&#243;n inusual de la sarcoidosis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "851"
          "paginaFinal" => "853"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Granulomatous Dactylitis&#58; An Unusual Finding in Sarcoidosis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1056
              "Ancho" => 1305
              "Tamanyo" => 168103
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Lesiones de lupus pernio faciales eritematosas con costra en superficie&#46; Dactilitis de 3 dedos del pie derecho asociada a onicopat&#237;a&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "I&#46; Garc&#237;a-Morales, E&#46; S&#225;nchez Garc&#237;a, A&#46; Crespo Cruz, J&#46; Escudero"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Garc&#237;a-Morales"
            ]
            1 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "S&#225;nchez Garc&#237;a"
            ]
            2 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Crespo Cruz"
            ]
            3 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Escudero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219021002365"
        "doi" => "10.1016/j.adengl.2021.07.024"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021002365?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173102100096X?idApp=UINPBA000044"
    "url" => "/00017310/0000011200000009/v1_202110020514/S000173102100096X/v1_202110020514/es/main.assets"
  ]
  "es" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fico-cl&#237;nica</span>"
    "titulo" => "Erupci&#243;n pitiriasis rosada-<span class="elsevierStyleItalic">like</span> inducida por imatinib en paciente con tumor del estroma gastrointestinal"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Sr&#46; Director&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "853"
        "paginaFinal" => "856"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "S&#46; Valenzuela-Ubi&#241;a, I&#46; Villegas-Romero, D&#46; Jim&#233;nez-Gallo, M&#46; Linares-Barrios"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "S&#46;"
            "apellidos" => "Valenzuela-Ubi&#241;a"
            "email" => array:1 [
              0 => "sandra.vzla@hotmail.es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "I&#46;"
            "apellidos" => "Villegas-Romero"
          ]
          2 => array:2 [
            "nombre" => "D&#46;"
            "apellidos" => "Jim&#233;nez-Gallo"
          ]
          3 => array:2 [
            "nombre" => "M&#46;"
            "apellidos" => "Linares-Barrios"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Unidad de Gesti&#243;n Cl&#237;nica de Dermatolog&#237;a M&#233;dico-Quir&#250;rgica y Venereolog&#237;a&#44; Hospital Universitario Puerta del Mar&#44; C&#225;diz&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2151
            "Ancho" => 2508
            "Tamanyo" => 539627
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; M&#250;ltiples m&#225;culas rosadas ovaladas con collarete de descamaci&#243;n&#44; distribuidas sim&#233;tricamente en ambos flancos&#46; B&#41; Detalle de las lesiones localizadas en flanco derecho&#46; C y D&#41; Detalle del collarete de descamaci&#243;n presente en algunas lesiones&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Imatinib es un inhibidor de tirosina-quinasa empleado para el tratamiento de la leucemia mieloide cr&#243;nica &#40;LMC&#41;&#44; los tumores del estroma gastrointestinal &#40;GIST&#41; y el dermatofibrosarcoma protuberans metast&#225;sico<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;5</span></a>&#46; Su mecanismo de acci&#243;n consiste en la inhibici&#243;n competitiva del sitio de uni&#243;n del adenos&#237;n trifosfato &#40;ATP&#41; que&#44; a su vez&#44; impide la fosforilaci&#243;n de las prote&#237;nas BCR-ABL&#44; c-kit y del receptor del factor de crecimiento derivado de plaquetas &#40;PDGFR&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;5&#8211;8</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Una mujer de 78 a&#241;os&#44; diagnosticada de un GIST metast&#225;sico y en tratamiento con imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a desde hac&#237;a un mes y medio&#44; consult&#243; por una erupci&#243;n cut&#225;nea abdominal ligeramente pruriginosa de una semana de evoluci&#243;n&#46; A la exploraci&#243;n se observaban unas m&#225;culas rosadas ovaladas con un collarete de descamaci&#243;n&#44; de distribuci&#243;n sim&#233;trica en ambos flancos &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; El estudio anal&#237;tico realizado fue normal&#44; incluyendo una serolog&#237;a para treponema negativa&#46; La histolog&#237;a revel&#243; una dermatitis espongi&#243;tica con un infiltrado perivascular de predominio linfocitario&#44; con ocasionales eosin&#243;filos y una paraqueratosis focal&#44; compatible con pitiriasis rosada &#40;PR&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#46; Debido al inicio reciente del tratamiento con imatinib y las caracter&#237;sticas histol&#243;gicas&#44; se diagnostic&#243; de erupci&#243;n PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Se suspendi&#243; imatinib y se instaur&#243; tratamiento con betametasona t&#243;pico y loratadina oral&#44; 20<span class="elsevierStyleHsp" style=""></span>mg cada 12<span class="elsevierStyleHsp" style=""></span>h&#44; con una resoluci&#243;n completa de la cl&#237;nica a las 2 semanas&#46; Dada la buena evoluci&#243;n&#44; se reanud&#243; el tratamiento con imatinib a dosis de 100<span class="elsevierStyleHsp" style=""></span>mg cada 12<span class="elsevierStyleHsp" style=""></span>h&#44; aument&#225;ndose progresivamente hasta alcanzar de nuevo los 400<span class="elsevierStyleHsp" style=""></span>mg diarios a las 3 semanas&#44; sin presentar nuevas lesiones cut&#225;neas&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Los efectos adversos de imatinib se clasifican en hematol&#243;gicos y no hematol&#243;gicos<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;8</span></a>&#46; Dentro de los efectos adversos no hematol&#243;gicos los m&#225;s frecuentes son los cut&#225;neos &#40;7-88&#44;9&#37; seg&#250;n series&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;4&#44;8</span></a>&#44; que suelen ser de intensidad leve-moderada&#44; dosis dependientes y no requieren la suspensi&#243;n permanente del f&#225;rmaco<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;4&#44;6&#8211;9</span></a>&#46; Para su tratamiento pueden emplearse antihistam&#237;nicos orales&#44; corticoides t&#243;picos o corticoterapia oral a dosis bajas<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3&#44;8</span></a>&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Las reacciones cut&#225;neas m&#225;s frecuentes son las inespec&#237;ficas&#44; aunque se han descrito casos de pustulosis exantem&#225;tica aguda generalizada&#44; s&#237;ndrome de Stevens-Johnson&#44; micosis fungoide-<span class="elsevierStyleItalic">like</span>&#44; erupciones psoriasiformes&#44; liquen erosivo oral&#44; dermatitis exfoliativas o dermatosis neutrof&#237;licas<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;4&#44;6&#8211;8</span></a>&#46; La erupci&#243;n PR-<span class="elsevierStyleItalic">like</span> es infrecuente y existen pocos casos en la literatura<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">La PR se caracteriza por la presencia de unas m&#225;culas eritematosas con una descamaci&#243;n fina perif&#233;rica en collarete&#44; asintom&#225;ticas o ligeramente pruriginosas&#44; que se resuelven espont&#225;neamente en varias semanas<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">9&#44;10</span></a>&#46; Su etiolog&#237;a es desconocida&#44; relacion&#225;ndose con infecciones como el virus herpes tipo 6 y 7<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">6&#44;9&#44;10</span></a>&#46; Existen tambi&#233;n casos descritos de PR-<span class="elsevierStyleItalic">like</span> inducida por f&#225;rmacos&#44; como omeprazol&#44; metronidazol&#44; terbinafina&#44; captopril&#44; D-penicilamina&#44; isotretino&#237;na&#44; nortriptilina&#44; sales de oro&#44; litio&#44; anti-TNF&#945; e imatinib<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;3&#44;6&#44;9&#44;10</span></a>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">El primer caso de PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib fue descrito por Konstantopoulos et al&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a>&#46; Todos los casos descritos de PR-<span class="elsevierStyleItalic">like</span> por imatinib mostraron lesiones t&#237;picas de PR en el tronco y las extremidades<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3&#44;6&#44;9&#44;10</span></a>&#46; Histol&#243;gicamente presentaron un infiltrado linfocitario perivascular superficial con ocasionales eosin&#243;filos&#44; espongiosis&#44; paraqueratosis focal y queratinocitos necr&#243;ticos&#44; en consonancia con nuestros hallazgos<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3&#44;6&#44;10</span></a>&#46; Algunos mostraban adem&#225;s acantosis y extravasaci&#243;n de hemat&#237;es<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3</span></a>&#46; En nuestra muestra no se realiz&#243; inmunohistoqu&#237;mica para linfocitos CD4&#47;CD8 &#40;podr&#237;a observarse predominio de linfocitos CD8 en epidermis y CD4 en dermis&#41; ni se apreciaban queratinocitos necr&#243;ticos o extravasaci&#243;n de hemat&#237;es&#44; que reforzar&#237;an el origen farmacol&#243;gico&#46; Sin embargo&#44; la histolog&#237;a compatible unida a la relaci&#243;n temporal entre el inicio del f&#225;rmaco y la aparici&#243;n de la cl&#237;nica &#40;mes y medio&#41;&#44; as&#237; como la r&#225;pida resoluci&#243;n &#40;2 semanas&#41; tras la suspensi&#243;n del mismo&#44; apoyan el diagn&#243;stico de PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib&#46; Dichos intervalos de tiempo fueron en consonancia con los recogidos en los otros casos descritos&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">La PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib suele remitir con la suspensi&#243;n del f&#225;rmaco&#44; pudiendo reaparecer si este se reintroduce a dosis elevadas &#40;300-400<span class="elsevierStyleHsp" style=""></span>mg diarios&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;3&#44;6</span></a>&#44; lo cual apoya el diagn&#243;stico en estos casos&#46; La relaci&#243;n entre prevalencia y dosis sugiere que es debida a sus efectos sobre la inhibici&#243;n de c-kit y&#47;o PDGFR&#44; los cuales se expresan en queratinocitos&#44; melanocitos&#44; mastocitos y gl&#225;ndulas sudor&#237;paras<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;4&#44;6&#8211;8</span></a>&#46; La cl&#237;nica de nuestra paciente se resolvi&#243; a las 2 semanas de suspender imatinib&#46; Sin embargo&#44; su reintroducci&#243;n no provoc&#243; que las lesiones volvieran a aparecer&#46; Ello podr&#237;a explicarse&#44; como afirman Cho et al&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a>&#44; por un incremento progresivo de dosis&#44; la cual se retom&#243; en nuestra paciente con 100<span class="elsevierStyleHsp" style=""></span>mg cada 12<span class="elsevierStyleHsp" style=""></span>h&#44; alcanzando los 400<span class="elsevierStyleHsp" style=""></span>mg diarios tras 3 semanas libres de lesiones&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Presentamos el que&#44; para nuestro conocimiento&#44; es el primer caso descrito de erupci&#243;n PR-<span class="elsevierStyleItalic">like</span> inducida por imatinib en una paciente con GIST&#46; Existen casos publicados de PR-<span class="elsevierStyleItalic">like</span> por imatinib en pacientes con leucemia mieloide cr&#243;nica &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Se trata de una reacci&#243;n poco frecuente y&#44; generalmente&#44; de car&#225;cter leve&#47;moderado que se resuelve al suspender el f&#225;rmaco&#46; Para prevenir la recidiva del cuadro se plantea la reintroducci&#243;n progresiva de imatinib o&#44; en el caso de GIST&#44; la sustituci&#243;n del mismo por sunitinib&#44; con el que no se han descrito casos&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicto de intereses</span><p id="par0050" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicto de intereses"
        ]
        1 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2151
            "Ancho" => 2508
            "Tamanyo" => 539627
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; M&#250;ltiples m&#225;culas rosadas ovaladas con collarete de descamaci&#243;n&#44; distribuidas sim&#233;tricamente en ambos flancos&#46; B&#41; Detalle de las lesiones localizadas en flanco derecho&#46; C y D&#41; Detalle del collarete de descamaci&#243;n presente en algunas lesiones&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 2152
            "Ancho" => 2508
            "Tamanyo" => 1364806
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A&#41; Imagen histol&#243;gica en la que destaca un infiltrado en dermis superficial&#46; B&#41; A mayor aumento se observa una dermatitis espongi&#243;tica con infiltrado perivascular y paraqueratosis focal&#46; C&#41; Detalle del infiltrado perivascular de predominio linfocitario&#46; D&#41; Detalle de la dermatitis espongi&#243;tica con un foco de paraqueratosis&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patolog&#237;a de base&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Sexo y edad&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tiempo tratamiento y dosis de imatinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Remisi&#243;n lesiones tras suspensi&#243;n&#46; Tratamiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Reinicio imatinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Plan de actuaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cho et al&#46;&#44; <span class="elsevierStyleItalic">Ann Dermatol&#46;</span> 2011&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 74 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 meses&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 semanas&#46; Antihistam&#237;nico oral y corticoide t&#243;pico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">400<span class="elsevierStyleHsp" style=""></span> mg&#47;d&#237;a&#44; reaparici&#243;n de lesiones tras 7 d&#237;as&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sustituci&#243;n por nilotinib&#46; No recurrencia de lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pasmatzi et al&#46;&#44; <span class="elsevierStyleItalic">Acta Derm Venereol&#46;</span> 2003&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 51 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 meses&#44; alternancia de 200-300<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 semanas&#46; Corticoides orales a dosis bajas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">300<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n de lesiones tras 6 d&#237;as&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Imatinib &#40;no precisa dosis&#41; &#43; 4<span class="elsevierStyleHsp" style=""></span>mg metilprednisolona oral d&#237;as alternos&#46; Remisi&#243;n lesiones en 4 meses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Verma et al&#46;&#44; <span class="elsevierStyleItalic">Indian J Dermatol&#46;</span> 2014&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Var&#243;n&#44; 24 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 semanas&#46; Sin tratamiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Aumento progresivo dosis imatinib hasta 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; corticoide t&#243;pico y antihistam&#237;nico oral&#46; Control lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Konstantopoulos et al&#46;&#44; <span class="elsevierStyleItalic">Dermatology&#46;</span> 2002&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 42 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No precisa si resoluci&#243;n&#46; Antihistam&#237;nico oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No se reinicia imatinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sustituci&#243;n por idarubicina &#43; citarabina &#43; corticoide oral&#46; Fallecimiento paciente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Brazzelli et al&#46;&#44; <span class="elsevierStyleItalic">J Am Acad Dermatol&#46;</span> 2005&#40;3 casos&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> LMC<span class="elsevierStyleItalic">2&#41;</span><span class="elsevierStyleBold">LMC</span><span class="elsevierStyleItalic">3&#41;</span> LMC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> Var&#243;n&#44; 58 a&#241;os<span class="elsevierStyleItalic">2&#41;</span> Var&#243;n&#44; 58 a&#241;os<span class="elsevierStyleItalic">3&#41;</span> Var&#243;n&#44; 35 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> 1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a<span class="elsevierStyleItalic">2&#41;</span> 1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a<span class="elsevierStyleItalic">3&#41;</span> 1 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> 2 semanas&#46; Antihistam&#237;nico oral<span class="elsevierStyleItalic">2&#41;</span> No precisa tiempo&#46; Antihistam&#237;nico y corticoide orales<span class="elsevierStyleItalic">3&#41;</span> No precisa tiempo&#46; Antihistam&#237;nico y corticoide orales&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones<span class="elsevierStyleItalic">2&#41;</span> 300<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones leves<span class="elsevierStyleItalic">3&#41;</span> 100<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a una semana y luego 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">1&#41;</span> Imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; Lesiones ocasionales&#44; no precisan tratamiento<span class="elsevierStyleItalic">2&#41;</span> Imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; Lesiones ocasionales&#44; no precisan tratamiento<span class="elsevierStyleItalic">3&#41;</span> Imatinib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; corticoide oral a dosis bajas&#46; Control lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nuestro caso&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">GIST&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mujer&#44; 78 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;5 mes&#44; 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 semanas&#46; Corticoide t&#243;pico y antihistam&#237;nico oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100<span class="elsevierStyleHsp" style=""></span>mg&#47;12<span class="elsevierStyleHsp" style=""></span>h&#44; no reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Aumento progresivo dosis imatinib hasta 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; No reaparici&#243;n lesiones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2708768.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Casos de pitiriasis rosada-<span class="elsevierStyleItalic">like</span> inducida por imatinib en la literatura cient&#237;fica</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea-like drug eruption induced by imatinib mesylate &#40;Gleevec&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46;Y&#46; Cho"
                            1 => "D&#46;H&#46; Kim"
                            2 => "M&#46; Im"
                            3 => "Y&#46; Lee"
                            4 => "Y&#46;J&#46; Seo"
                            5 => "J&#46;H&#46; Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5021/ad.2011.23.S3.S360"
                      "Revista" => array:7 [
                        "tituloSerie" => "Ann Dermatol&#46;"
                        "fecha" => "2011"
                        "volumen" => "23"
                        "numero" => "Suppl&#46; 3"
                        "paginaInicial" => "S360"
                        "paginaFinal" => "S363"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22346278"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "E&#46; Pasmatzi"
                            1 => "A&#46; Monastirli"
                            2 => "P&#46; Matsouka"
                            3 => "D&#46; Tsambaos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/00015550310012593"
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Derm Venereol&#46;"
                        "fecha" => "2003"
                        "volumen" => "83"
                        "paginaInicial" => "391"
                        "paginaFinal" => "392"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14609118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Imatinib mesylate-induced cutaneous rash masquerading as pitiriasis rosea of Gilbert"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "P&#46; Verma"
                            1 => "A&#46; Singal"
                            2 => "S&#46; Sharma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4103/0019-5154.131433"
                      "Revista" => array:6 [
                        "tituloSerie" => "Indian J Dermatol&#46;"
                        "fecha" => "2014"
                        "volumen" => "59"
                        "paginaInicial" => "311"
                        "paginaFinal" => "312"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24891677"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Skin lesions in patients treated with imatinib mesylate&#58; A 5-year prospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Paolino"
                            1 => "D&#46; Didona"
                            2 => "R&#46; Clerico"
                            3 => "P&#46; Corsetti"
                            4 => "M&#46; Ambrifi"
                            5 => "U&#46; Bottoni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Cutis"
                        "fecha" => "2016"
                        "volumen" => "97"
                        "paginaInicial" => "E12"
                        "paginaFinal" => "E16"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Approval summary&#58; imatinib mesylate in the treatment of metastatic and&#47;or unresectable malignant gastrointestinal stromal tumors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Dagher"
                            1 => "M&#46; Cohen"
                            2 => "G&#46; Williams"
                            3 => "M&#46; Rothmann"
                            4 => "J&#46; Gobburu"
                            5 => "G&#46; Robbie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Cancer Res&#46;"
                        "fecha" => "2002"
                        "volumen" => "8"
                        "paginaInicial" => "3034"
                        "paginaFinal" => "3038"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12374669"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea-like eruption during treatment with imatinib mesylate&#58; description of 3 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; Brazzelli"
                            1 => "F&#46; Prestinari"
                            2 => "E&#46; Roveda"
                            3 => "T&#46; Barbagallo"
                            4 => "E&#46; Bellani"
                            5 => "C&#46; Vassallo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2004.10.888"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2005"
                        "volumen" => "53"
                        "numero" => "5 Suppl&#46; 1"
                        "paginaInicial" => "S240"
                        "paginaFinal" => "S243"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16227099"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse cutaneous reactions to imatinib &#40;STI571&#41; in Philadelphia chromosome-positive leukemias&#58; a prospective study of 54 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Valeyrie"
                            1 => "S&#46; Bustuji-Garin"
                            2 => "J&#46; Revuz"
                            3 => "N&#46; Bachot"
                            4 => "J&#46; Wechsler"
                            5 => "P&#46; Berthaud"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1067/mjd.2003.44"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2003"
                        "volumen" => "48"
                        "paginaInicial" => "201"
                        "paginaFinal" => "206"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12582389"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia&#58; A 6-year follow up"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "E&#46; Dervis"
                            1 => "M&#46; Ayer"
                            2 => "S&#46; Akin Belli"
                            3 => "S&#46;G&#46; Barut"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1684/ejd.2015.2684"
                      "Revista" => array:5 [
                        "tituloSerie" => "Eur J Dermatol&#46;"
                        "fecha" => "2016"
                        "volumen" => "26"
                        "paginaInicial" => "133"
                        "paginaFinal" => "137"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea associated with Imatinib &#40;STI571&#44; Gleevec&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "K&#46; Konstantopoulos"
                            1 => "A&#46; Papadogianni"
                            2 => "M&#46; Dimopoulou"
                            3 => "C&#46; Kourelis"
                            4 => "J&#46; Meletis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000063900"
                      "Revista" => array:5 [
                        "tituloSerie" => "Dermatology&#46;"
                        "fecha" => "2002"
                        "volumen" => "205"
                        "paginaInicial" => "172"
                        "paginaFinal" => "173"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;K&#46; Bangash"
                            1 => "T&#46; Finch"
                            2 => "V&#46; Petronic-Rosic"
                            3 => "A&#46; Sethi"
                            4 => "E&#46; Abramsohn"
                            5 => "S&#46;T&#46; Lindau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/LGT.0b013e31825d7c5f"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Low Genit Tract Dis&#46;"
                        "fecha" => "2013"
                        "volumen" => "17"
                        "paginaInicial" => "226"
                        "paginaFinal" => "229"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23343697"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011200000009/v1_202110020514/S0001731021000958/v1_202110020514/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6160"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas cient&#237;fico-cl&#237;nicas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011200000009/v1_202110020514/S0001731021000958/v1_202110020514/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021000958?idApp=UINPBA000044"
]
Article information
ISSN: 00017310
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 35 11 46
2024 October 292 76 368
2024 September 296 45 341
2024 August 289 69 358
2024 July 279 45 324
2024 June 277 57 334
2024 May 412 45 457
2024 April 297 44 341
2024 March 363 32 395
2024 February 310 33 343
2024 January 259 43 302
2023 December 221 26 247
2023 November 283 38 321
2023 October 214 32 246
2023 September 197 40 237
2023 August 90 18 108
2023 July 154 60 214
2023 June 126 26 152
2023 May 190 42 232
2023 April 131 24 155
2023 March 138 31 169
2023 February 153 31 184
2023 January 120 26 146
2022 December 113 48 161
2022 November 194 53 247
2022 October 164 46 210
2022 September 115 58 173
2022 August 132 67 199
2022 July 123 61 184
2022 June 117 43 160
2022 May 157 52 209
2022 April 121 39 160
2022 March 116 73 189
2022 February 100 46 146
2022 January 133 56 189
2021 December 128 48 176
2021 November 119 45 164
2021 October 192 105 297
2021 September 68 54 122
2021 August 113 28 141
2021 July 83 30 113
2021 June 113 46 159
2021 May 65 46 111
2021 April 191 116 307
2021 March 61 108 169
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?